Law & Politics The FDA’s data on mifepristone can’t be trusted — here’s why Nermeen Nabil June 18, 2026 For the review to withstand the necessary scrutiny it will face upon publication, the FDA must prioritize robust, real-world data sources. Continue Reading Previous: The Speedy Particles That Could Help Us Learn More About UranusNext: Obama Presidential Center opens Thursday: Here’s what to know Related Stories Law & Politics Raskin demands full list of Trump medications, doctors’ names Nermeen Nabil June 18, 2026 Law & Politics Vance hits back at Iran deal critics in GOP, Israel: Five takeaways Nermeen Nabil June 18, 2026 Law & Politics Iran supreme leader says he approved MOU despite reservations Nermeen Nabil June 18, 2026